Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Deoxyglucose SCHEMBL29105105 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL307650 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL148114 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL2315642 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL3019708 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL2065929 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL120125 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL10386937 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL200714 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 | |
| Deoxyglucose SCHEMBL635056 | 1.00 | LMNA (0.50) | LMNAL3MBTL1TDP1PDE4AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019150578-A1 | METHOD FOR PREPARING CYCLOPENTENONE | 株式会社コンポン研究所 | 2019-08-08 | — | — | WO | disclosed |
| US-7511160-B2 | Lactone derivative and its manufacturing method | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2009-03-31 | — | — | US | disclosed |
| US-20060058536-A1 | Lactone derivative and its manufacturing method | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2006-03-16 | — | — | US | disclosed |
| EP-0390783-A1 | METHOD FOR IMPROVING THE FEED CONVERSION EFFICIENCY OF MEAT-PRODUCING ANIMALS BY ORAL ADMINISTRATION OF 2-DEOXY-D-HEXOSE | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1990-10-10 | — | — | EP | disclosed |
| US-4937077-A | Method for improving feed conversion of meat-producing animals by oral administration of 2-deoxy-D-hexose | EASTMAN KODAK COMPANY (US) | 1990-06-26 | — | — | US | disclosed |
| WO-1989002224-A1 | METHOD FOR IMPROVING THE FEED CONVERSION EFFICIENCY OF MEAT-PRODUCING ANIMALS BY ORAL ADMINISTRATION OF 2-DEOXY-D-HEXOSE | EASTMAN KODAK COMPANY (US) | 1989-03-23 | — | — | WO | disclosed |
| CN-85107911-A | The production method of ellipticine derivative | — | 1987-02-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058536-A1 | Lactone derivative and its manufacturing method | CYP51A1, LSS, MRPL21 | LMNA 1688/4885L3MBTL1 1173/4885TDP1 4721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.